Literature DB >> 12801513

Possible involvement of mitogen-activated protein kinase in the angiotensin II-induced fibronectin synthesis in renal interstitial fibroblasts.

Shizue Sekine1, Kosaku Nitta, Keiko Uchida, Wako Yumura, Hiroshi Nihei.   

Abstract

Angiotensin II (AT II) is thought to be associated with the development of renal interstitial fibrosis. However, the molecular mechanisms of the interstitial fibrosis have not been extensively studied. We have examined the role of mitogen-activated protein kinases (MAPKs) on fibronectin (FN) accumulation in cultured normal rat kidney interstitial fibroblasts (NRK 49F cell line). AT II caused dose-dependent increases in FN accumulation and FN mRNA in these cells. AT II also activated the extracellular signal-regulated kinase (ERK) and p38 MAPK in the presence of AT II. These increases in FN accumulation and activation of MAPKs were inhibited with AT I receptor antagonist (ARB; CV-11974) in renal interstitial fibroblasts. The inhibitors against ERK (PD98059) and p38 MAPK (SB203580) significantly inhibited AT II-induced increases in FN mRNA. These findings suggest that the MAPKs play an important role in AT II-mediated renal interstitial fibrosis and that ARB may be useful for preventing renal interstitial fibrosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12801513     DOI: 10.1016/s0003-9861(03)00163-2

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  9 in total

1.  Angiotensin II stimulates fibronectin protein synthesis via a Gβγ/arachidonic acid-dependent pathway.

Authors:  Larry D Alexander; Yaxian Ding; Suganthi Alagarsamy; Xiaolan Cui
Journal:  Am J Physiol Renal Physiol       Date:  2014-06-11

2.  Delayed administration of suramin attenuates the progression of renal fibrosis in obstructive nephropathy.

Authors:  Na Liu; Evelyn Tolbert; Murugavel Ponnusamy; Haidong Yan; Shougang Zhuang
Journal:  J Pharmacol Exp Ther       Date:  2011-05-27       Impact factor: 4.030

3.  Effects and mechanism of irbesartan on tubulointerstitial fibrosis in 5/6 nephrectomized rats.

Authors:  Gang Zhao; Hong Zhao; Ling Tu; Xizhen Xu; Changlong Zheng; Meihua Jiang; Peihua Wang; Daowen Wang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2010-02-14

4.  Candesartan prevents arteriopathy progression in cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy model.

Authors:  Taisuke Kato; Ri-Ichiroh Manabe; Hironaka Igarashi; Fuyuki Kametani; Sachiko Hirokawa; Yumi Sekine; Natsumi Fujita; Satoshi Saito; Yusuke Kawashima; Yuya Hatano; Shoichiro Ando; Hiroaki Nozaki; Akihiro Sugai; Masahiro Uemura; Masaki Fukunaga; Toshiya Sato; Akihide Koyama; Rie Saito; Atsushi Sugie; Yasuko Toyoshima; Hirotoshi Kawata; Shigeo Murayama; Masaki Matsumoto; Akiyoshi Kakita; Masato Hasegawa; Masafumi Ihara; Masato Kanazawa; Masatoyo Nishizawa; Shoji Tsuji; Osamu Onodera
Journal:  J Clin Invest       Date:  2021-11-15       Impact factor: 14.808

5.  Role of p38 mitogen-activated protein kinase in middle ear mucosa hyperplasia during bacterial otitis media.

Authors:  Sean D Palacios; Kwang Pak; Alexander Z Rivkin; Ayse G Kayali; Darrell Austen; Christoph Aletsee; Asa Melhus; Nicholas J G Webster; Allen F Ryan
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

Review 6.  Angiotensin II Type I Receptor (AT1R): The Gate towards COVID-19-Associated Diseases.

Authors:  George El-Arif; Shaymaa Khazaal; Antonella Farhat; Julien Harb; Cédric Annweiler; Yingliang Wu; Zhijian Cao; Hervé Kovacic; Ziad Abi Khattar; Ziad Fajloun; Jean-Marc Sabatier
Journal:  Molecules       Date:  2022-03-22       Impact factor: 4.411

7.  Angiotensin II Receptor Blockers (ARBs Antihypertensive Agents) Increase Replication of SARS-CoV-2 in Vero E6 Cells.

Authors:  Gabriel Augusto Pires de Souza; Ikram Omar Osman; Marion Le Bideau; Jean-Pierre Baudoin; Rita Jaafar; Christian Devaux; Bernard La Scola
Journal:  Front Cell Infect Microbiol       Date:  2021-06-11       Impact factor: 5.293

8.  Fimasartan, a Novel Angiotensin-Receptor Blocker, Protects against Renal Inflammation and Fibrosis in Mice with Unilateral Ureteral Obstruction: the Possible Role of Nrf2.

Authors:  Soojeong Kim; Sung Jun Kim; Hye Eun Yoon; Sungjin Chung; Bum Soon Choi; Cheol Whee Park; Seok Joon Shin
Journal:  Int J Med Sci       Date:  2015-10-21       Impact factor: 3.738

Review 9.  The Emerging Role of Innate Immunity in Chronic Kidney Diseases.

Authors:  Philip Chiu-Tsun Tang; Ying-Ying Zhang; Max Kam-Kwan Chan; Winson Wing-Yin Lam; Jeff Yat-Fai Chung; Wei Kang; Ka-Fai To; Hui-Yao Lan; Patrick Ming-Kuen Tang
Journal:  Int J Mol Sci       Date:  2020-06-04       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.